Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Oncology
|
April 1, 1989
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma
E T Creagan, J N Ingle, A J Schutt, et al.
Cancer
|
December 15, 1988
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma
E T Creagan, C L Loprinzi, D L Ahmann, et al.
Cancer
|
August 11, 1975
Six families prone to ovarian cancer
J F Fraumeni, G W Grundy, E T Creagan, et al.
American Journal of Surgery
|
October 1, 1979
Radiation therapy for malignant melanoma of the head and neck
E T Creagan, J E Woods, R E Cupps, et al.
American Journal of Clinical Oncology
|
June 1, 1993
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma
E T Creagan, D J Schaid, L C Hartmann, et al.
Cancer
|
April 1, 1982
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
E T Creagan, J N Ingle, D L Ahmann, et al.
Oncology
|
January 1, 1977
A clinical trial adriamycin (NSC 123127) in advanced sarcomas
E T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology
|
January 1, 1986
Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma
E T Creagan, A J Schutt, H J Long, et al.
American Journal of Clinical Oncology
|
April 1, 1991
A technetium-labeled monoclonal antibody for imaging metastatic melanoma
S Frytak, E T Creagan, M L Brown, et al.
American Journal of Clinical Oncology
|
June 1, 1992
Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma
E R Feldman, E T Creagan, D J Schaid, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Oncology
|
April 1, 1989
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma
E T Creagan, J N Ingle, A J Schutt, et al.
Cancer
|
December 15, 1988
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma
E T Creagan, C L Loprinzi, D L Ahmann, et al.
Cancer
|
August 11, 1975
Six families prone to ovarian cancer
J F Fraumeni, G W Grundy, E T Creagan, et al.
American Journal of Surgery
|
October 1, 1979
Radiation therapy for malignant melanoma of the head and neck
E T Creagan, J E Woods, R E Cupps, et al.
American Journal of Clinical Oncology
|
June 1, 1993
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma
E T Creagan, D J Schaid, L C Hartmann, et al.
Cancer
|
April 1, 1982
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
E T Creagan, J N Ingle, D L Ahmann, et al.
Oncology
|
January 1, 1977
A clinical trial adriamycin (NSC 123127) in advanced sarcomas
E T Creagan, R G Hahn, D L Ahmann, et al.
Medical and Pediatric Oncology
|
January 1, 1986
Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma
E T Creagan, A J Schutt, H J Long, et al.
American Journal of Clinical Oncology
|
April 1, 1991
A technetium-labeled monoclonal antibody for imaging metastatic melanoma
S Frytak, E T Creagan, M L Brown, et al.
American Journal of Clinical Oncology
|
June 1, 1992
Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma
E R Feldman, E T Creagan, D J Schaid, et al.
Page
of 12